Matches in Nanopublications for { ?s ?p "[Further, we identify a novel subgroup of patients with CLL with early progressive disease that appears particularly sensitive to MDM2 inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP293394.RAYmSbAMkuz81WBmLoE2D1KPYfswjlrdASSYNE6EYyhKY130_assertion description "[Further, we identify a novel subgroup of patients with CLL with early progressive disease that appears particularly sensitive to MDM2 inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293394.RAYmSbAMkuz81WBmLoE2D1KPYfswjlrdASSYNE6EYyhKY130_provenance.
- NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_assertion description "[Further, we identify a novel subgroup of patients with CLL with early progressive disease that appears particularly sensitive to MDM2 inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551408.RADo9qBT-HFfc3KmAnQIMtE2fudnJRM5I0QeQ4nuqpXHg130_provenance.
- NP637879.RA_80KsuyIPBxcW-zj-cMu0yGPwzGOtKXR0Dg4OpY4I_w130_assertion description "[Further, we identify a novel subgroup of patients with CLL with early progressive disease that appears particularly sensitive to MDM2 inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637879.RA_80KsuyIPBxcW-zj-cMu0yGPwzGOtKXR0Dg4OpY4I_w130_provenance.
- NP551071.RAGAVkJkKYsuEBAR19RU1H0CrdSURKUNz6xUC8bCLap9Q130_assertion description "[Further, we identify a novel subgroup of patients with CLL with early progressive disease that appears particularly sensitive to MDM2 inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551071.RAGAVkJkKYsuEBAR19RU1H0CrdSURKUNz6xUC8bCLap9Q130_provenance.
- assertion description "[Further, we identify a novel subgroup of patients with CLL with early progressive disease that appears particularly sensitive to MDM2 inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Further, we identify a novel subgroup of patients with CLL with early progressive disease that appears particularly sensitive to MDM2 inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_assertion description "[Further, we identify a novel subgroup of patients with CLL with early progressive disease that appears particularly sensitive to MDM2 inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637883.RAJUb4qvJ5B7LOWBaptCTCHN8gU0rVR0-xkdjWwmqPSMc130_provenance.